BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a supportive therapy used for severe acute respiratory distress syndrome (ARDS). We present outcome, clinical parameters, and complications in a cohort of 245 ARDS patients of whom 62 were treated with ECMO. METHODS: Data of all ARDS patients were prospectively collected between 1991 and 1999. Outcome and clinical parameters of patients treated with and without ECMO were evaluated. RESULTS: One hundred thirty-eight patients were referred from other hospitals, 107 were primarily located in our hospital. About one fourth of these patients were treated with ECMO. The survival rate was 55% in ECMO patients and 61% in non-ECMO patients. CONCLUSIONS: ECMO is a therapeutic option for patients with severe ARDS, likely to increase survival. However, a randomized controlled study proving its benefit is still awaited. Until the development of a causal or otherwise superior therapy ECMO should be used in selected patients.
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a supportive therapy used for severe acute respiratory distress syndrome (ARDS). We present outcome, clinical parameters, and complications in a cohort of 245 ARDSpatients of whom 62 were treated with ECMO. METHODS: Data of all ARDSpatients were prospectively collected between 1991 and 1999. Outcome and clinical parameters of patients treated with and without ECMO were evaluated. RESULTS: One hundred thirty-eight patients were referred from other hospitals, 107 were primarily located in our hospital. About one fourth of these patients were treated with ECMO. The survival rate was 55% in ECMO patients and 61% in non-ECMO patients. CONCLUSIONS: ECMO is a therapeutic option for patients with severe ARDS, likely to increase survival. However, a randomized controlled study proving its benefit is still awaited. Until the development of a causal or otherwise superior therapy ECMO should be used in selected patients.
Authors: Trevor A Snyder; Heide J Eash; Kenneth N Litwak; Brian J Frankowski; Brack G Hattler; William J Federspiel; William R Wagner Journal: Artif Organs Date: 2006-09 Impact factor: 3.094
Authors: Christian Karagiannidis; Matthias Lubnow; Alois Philipp; Guenter A J Riegger; Christof Schmid; Michael Pfeifer; Thomas Mueller Journal: Intensive Care Med Date: 2010-08-06 Impact factor: 17.440
Authors: Jonathan D Marhong; Laveena Munshi; Michael Detsky; Teagan Telesnicki; Eddy Fan Journal: Intensive Care Med Date: 2015-03-10 Impact factor: 17.440
Authors: Thomas Müller; Alois Philipp; Andreas Luchner; Christian Karagiannidis; Thomas Bein; Michael Hilker; Leopold Rupprecht; Julia Langgartner; Markus Zimmermann; Matthias Arlt; Jan Wenger; Christof Schmid; Günter Aj Riegger; Michael Pfeifer; Matthias Lubnow Journal: Crit Care Date: 2009-12-17 Impact factor: 9.097